Absorica LD
Drug Dermatology
NDC 10631-002-31
General payments
$1,748,306
Research payments
$74,963
Through program year 2025, $1,748,306 in general payments and $74,963 in research payments were reported against Absorica LD (Dermatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,094 | 11 |
| 2024 | General | $190,532 | 7,134 |
| 2023 | General | $665,370 | 14,783 |
| 2023 | Research | $59,970 | 2 |
| 2022 | General | $339,300 | 9,835 |
| 2021 | General | $315,455 | 11,790 |
| 2021 | Research | $14,993 | 1 |
| 2020 | General | $236,557 | 3,940 |
Breakdown
The top 5 of 11 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
47,493 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.